Influenza vaccination in the elderly

Figures & data

Table 1. Influenza vaccines licensed for elderly in the European Union and United States.

Flu Vaccine (Tradename)	Vaccine Type	Age recommended	Manufacturer
Vaccines Licensed for Use in the European Union^1
Vaxigrip	Inactivated, adjuvanted, trivalent	6 months and older	Sanofi Pasteur
Vaxigrip Tetra	Inactivated, quadrivalent	3 y and older	Sanofi Pasteur
Intanza 15µg	Inactivated, trivalent	60 y and older	Sanofi Pasteur
Fluarix	Inactivated, trivalent	6 months and older	GlaxoSmithKline
Fluarix Tetra	Inactivated, quadrivalent	3 y and older	GlaxoSmithKline
Fluad	Inactivated, adjuvanted, trivalent	65 y and old	Novartis
Optaflu	Inactivated, trivalent	18 y and older	Novartis
Agrippal	Inactivated, trivalent	6 months and older	Novartis
Fluvirin	Inactivated, trivalent	4 y and older	Novartis
Influvac	Inactivated, trivalent	6 months and older	BGP Products B.V.
Foclivia	Inactivated, adjuvanted, monovalent (H5N1)	18 y and older	Seqirus
Aflunox	Inactivated, adjuvanted, monovalent (H5N1)	18 y and older	Seqirus
Vaccines Licensed for Use in the United States^2
Fluad	Inactivated, adjuvanted, trivalent	65 y and older	Seqirus
Afluria	Inactivated, trivalent	5 y and older	Seqirus
Afluria quadrivalent	Inactivated, quadrivalent	18 y and older	Seqirus
Flucelvax quadrivalent	Inactivated, quadrivalent	4 y and older	Seqirus
FluLaval	Inactivated, trivalent	6 months and older	ID Biomedical Corporation
FluLaval Quadrivalent	Inactivated, quadrivalent	6 months and older	ID Biomedical Corporation
Fluarix	Inactivated, trivalent	3 y and older	GlaxoSmithKline
Fluarix quadrivalent	Inactivated, quadrivalent	3 y and older	GlaxoSmithKline
Fluvirin	Inactivated, trivalent	4 y and older	Seqirus
Agriflu	Inactivated, trivalent	4 y and older	Novartis
Fluzone High Dos	Inactivated, trivalent	65 y and older	Sanofi Pasteur
Fluzone quadrivalent	Inactivated, quadrivalent	6 months and older	Sanofi Pasteur
Flucelvax	Inactivated, trivalent	4 y and older	Seqirus
Flublok	Inactivated, trivalent	18 y and older	Protein Science Corporation
Flublok Quadrivalent	Inactivated, quadrivalent	18 y and older	Protein Science Corporation
Influenza Virus Vaccine H5N1 (no Trade Name)^3	Inactivated, adjuvanted, monovalent	18 y and older	Sanofi Pasteur

¹ Approved by European Medicine Agency (EMA)

² Approved by Food and Drug Administration (FDA)

³ Only for National Stockpile

Table 2. Influenza vaccine recommendations for the elderly in Europe and selected countries.

Country	Recommendation for elderly	Target age group
Poland	YES	≥ 55 years
Germany, Greece, Hungry, Iceland, Netherlands, Slovakia	YES	≥ 60 years
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Norway, Portugal, Romania, Slovenia, Spain, Sweden, United Kingdom^1)	YES	≥ 65 years
Russia^2)	YES	≥ 60 years
Australia^3)	YES	≥ 65 years
United States^4)	YES	All adults
Canada^5)	YES	All adults
Israel^6)	YES	≥ 65 y

¹⁾ ECDC Vaccine schedule: influenza

²⁾ Ministry of Public Health of Russia

³⁾ Australian Government, Department of Health, Australian Technical Advisory Group on Immunization (ATAGI)

⁴⁾ CDC Atlanta, Advisory Committee for Immunization Practices (ACIP)

⁵⁾ Public Health Agency of Canada, National Advisory Committee on Immunization (NACI)

⁶⁾ Ministry of Health, Israel